Bakewell Veterinary Clinic Limited 07451596 false 2025-01-01 2025-12-31 2025-12-31 The principal activity of the company is the provision of veterinarian services. Digita Accounts Production Advanced 6.30.9574.0 true 07451596 2025-01-01 2025-12-31 07451596 2025-12-31 07451596 core:RetainedEarningsAccumulatedLosses 2025-12-31 07451596 core:ShareCapital 2025-12-31 07451596 core:CurrentFinancialInstruments 2025-12-31 07451596 core:CurrentFinancialInstruments core:WithinOneYear 2025-12-31 07451596 core:Non-currentFinancialInstruments core:AfterOneYear 2025-12-31 07451596 core:Goodwill 2025-12-31 07451596 core:ConstructionInProgressAssetsUnderConstruction 2025-12-31 07451596 core:FurnitureFittings 2025-12-31 07451596 core:MotorVehicles 2025-12-31 07451596 core:PlantMachinery 2025-12-31 07451596 bus:SmallEntities 2025-01-01 2025-12-31 07451596 bus:AuditExemptWithAccountantsReport 2025-01-01 2025-12-31 07451596 bus:FilletedAccounts 2025-01-01 2025-12-31 07451596 bus:SmallCompaniesRegimeForAccounts 2025-01-01 2025-12-31 07451596 bus:Director1 2025-01-01 2025-12-31 07451596 bus:Director2 2025-01-01 2025-12-31 07451596 bus:PrivateLimitedCompanyLtd 2025-01-01 2025-12-31 07451596 core:Goodwill 2025-01-01 2025-12-31 07451596 core:ConstructionInProgressAssetsUnderConstruction 2025-01-01 2025-12-31 07451596 core:FurnitureFittings 2025-01-01 2025-12-31 07451596 core:FurnitureFittingsToolsEquipment 2025-01-01 2025-12-31 07451596 core:MotorVehicles 2025-01-01 2025-12-31 07451596 core:OfficeEquipment 2025-01-01 2025-12-31 07451596 core:PlantMachinery 2025-01-01 2025-12-31 07451596 countries:AllCountries 2025-01-01 2025-12-31 07451596 2024-12-31 07451596 core:Goodwill 2024-12-31 07451596 core:ConstructionInProgressAssetsUnderConstruction 2024-12-31 07451596 core:FurnitureFittings 2024-12-31 07451596 core:MotorVehicles 2024-12-31 07451596 core:PlantMachinery 2024-12-31 07451596 2024-01-01 2024-12-31 07451596 2024-12-31 07451596 core:RetainedEarningsAccumulatedLosses 2024-12-31 07451596 core:ShareCapital 2024-12-31 07451596 core:CurrentFinancialInstruments 2024-12-31 07451596 core:CurrentFinancialInstruments core:WithinOneYear 2024-12-31 07451596 core:Non-currentFinancialInstruments core:AfterOneYear 2024-12-31 07451596 core:Goodwill 2024-12-31 07451596 core:ConstructionInProgressAssetsUnderConstruction 2024-12-31 07451596 core:FurnitureFittings 2024-12-31 07451596 core:MotorVehicles 2024-12-31 07451596 core:PlantMachinery 2024-12-31 iso4217:GBP xbrli:pure

Registration number: 07451596

Bakewell Veterinary Clinic Limited
Unaudited Financial Statements
for the Year Ended 31 December 2025

Bakewell Veterinary Clinic Limited

(Registration number: 07451596)
Balance Sheet as at 31 December 2025

| Note | 2025 £ | 2024 £
Fixed assets |  |  |
Intangible assets | 3 | - | -
Tangible assets | 4 | 115,809 | 157,918
|  | 115,809 | 157,918
Current assets |  |  |
Stocks |  | 115,384 | 83,300
Debtors | 5 | 405,077 | 406,668
Cash at bank and in hand |  | 364,162 | 214,683
|  | 884,623 | 704,651
Creditors: Amounts falling due within one year | 6 | (758,642) | (669,819)
Net current assets |  | 125,981 | 34,832
Total assets less current liabilities |  | 241,790 | 192,750
Creditors: Amounts falling due after more than one year | 6 | - | (5,286)
Provisions for liabilities |  | (28,952) | (39,480)
Net assets |  | 212,838 | 147,984
Capital and reserves |  |  |
Called up share capital |  | 4,000 | 4,000
Retained earnings |  | 208,838 | 143,984
Shareholders' funds |  | 212,838 | 147,984

Bakewell Veterinary Clinic Limited

(Registration number: 07451596)
Balance Sheet as at 31 December 2025 (continued)

For the financial year ending 31 December 2025 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.

Directors' responsibilities:

• | The members have not required the company to obtain an audit of its accounts for the year in question in accordance with section 476; and
• | The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of accounts.

These financial statements have been delivered in accordance with the provisions applicable to companies subject to the small companies regime and the option not to file the Directors' Report and the Profit and Loss Account has been taken.

These financial statements, which have been prepared in accordance with the special provisions relating to companies subject to the small companies regime within Part 15 of the Companies Act 2006 and in accordance with the provisions of FRS 102 Section 1A Small Entities, were approved and authorised by the Board on 24 March 2026 and signed on its behalf by:

......................................... G W Bramwell Director | ......................................... W J Schaper Director |

Bakewell Veterinary Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025

1 | Accounting policies

Statutory information

Bakewell Veterinary Clinic Limited is a private company, limited by shares, domiciled in England and Wales, company number 07451596. The registered office is at Milford Farm, Mill Street, Bakewell, DE45 1DX.

Summary of significant accounting policies and key accounting estimates

The principal accounting policies applied in the preparation of these financial statements are set out below. These policies have been consistently applied to all the years presented, unless otherwise stated.

Statement of compliance

These financial statements have been prepared in accordance with Financial Reporting Standard 102 Section 1A - 'The Financial Reporting Standard applicable in the UK and Republic of Ireland' and the Companies Act 2006.

Basis of preparation

These financial statements have been prepared using the historical cost convention except that as disclosed in the accounting policies certain items are shown at fair value. The presentation currency is United Kingdom pounds sterling, which is the functional currency of the company. The financial statements are those of an individual entity.

Revenue recognition

Turnover comprises the fair value of the consideration received or receivable for the sale of goods and provision of services in the ordinary course of the company’s activities. Turnover is shown net of sales/value added tax, returns, rebates and discounts. Revenue is recognised at the point of sale or upon the delivery of services.

Tax

The tax expense for the period comprises current and deferred tax. Tax is recognised in profit or loss, except that a change attributable to an item of income or expense recognised as other comprehensive income is also recognised directly in other comprehensive income.

The current income tax charge is calculated on the basis of tax rates and laws that have been enacted or substantively enacted by the reporting date in the countries where the company operates and generates taxable income.

Deferred tax is recognised in respect of all timing differences between taxable profits and profits reported in the financial statements.
Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date and that are expected to apply to the reversal of the timing difference.

Tangible assets

Tangible assets are stated in the balance sheet at cost, less any subsequent accumulated depreciation and subsequent accumulated impairment losses.
The cost of tangible assets includes directly attributable incremental costs incurred in their acquisition and installation.

Bakewell Veterinary Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025 (continued)

1 | Accounting policies (continued)

Depreciation

Depreciation is charged so as to write off the cost of assets over their estimated useful lives, as follows:

Asset class | Depreciation method and rate
Plant and machinery | 20%/25% straight line
Fixtures and fittings | 20% straight line
Motor vehicles | 25% straight line
Office equipment | 10%/33% straight line

Goodwill

Goodwill arising on the acquisition of an entity represents the excess of the cost of acquisition over the company’s interest in the net fair value of the identifiable assets, liabilities and contingent liabilities of the entity recognised at the date of acquisition. Goodwill is initially recognised as an asset at cost and is subsequently measured at cost less accumulated amortisation and accumulated impairment losses. Goodwill is held in the currency of the acquired entity and revalued to the closing rate at each reporting period date. Goodwill is amortised over its useful life, which shall not exceed ten years if a reliable estimate of the useful life cannot be made.

Amortisation

Amortisation is provided on intangible assets so as to write off the cost, less any estimated residual value, over their useful life as follows:

Asset class | Amortisation method and rate
Goodwill | 3 and 10 years straight line

Stocks

Stock is valued at the lower of cost and net realisable value, after due regard for obsolete and slow moving stocks. Net realisable value is based on selling price less anticipated costs to completion and selling costs.

Defined contribution pension obligation

Contributions to defined contribution plans are recognised as employee benefit expense when they are due. If contribution payments exceed the contribution due for service, the excess is recognised as a prepayment.

Financial instruments

Financial instruments are classified and accounted for, according to the substance of the contractual arrangement, as financial assets, financial liabilities or equity instruments. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities. Where shares are issued, any component that creates a financial liability of the company is presented as a liability in the balance sheet. The corresponding dividends relating to the liability component are charged as interest expense in the statement of comprehensive income.

2 | Staff numbers

The average number of persons employed by the company (including directors) during the year, was 27 (2024 - 27).

Bakewell Veterinary Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025 (continued)

3 | Intangible assets

| Goodwill £
Cost or valuation
At 1 January 2025 | 673,250
At 31 December 2025 | 673,250
Amortisation
At 1 January 2025 | 673,250
At 31 December 2025 | 673,250
Carrying amount
At 31 December 2025 | -
At 31 December 2024 | -

4 | Tangible assets

| Plant and machinery £ | Fixtures and fittings £ | Motor vehicles £ | Office equipment £ | Total £
Cost
At 1 January 2025 | 407,547 | 38,901 | 104,460 | 66,258 | 617,166
Additions | 19,388 | - | - | - | 19,388
Disposals | (38,082) | (15,392) | - | (7,183) | (60,657)
At 31 December 2025 | 388,853 | 23,509 | 104,460 | 59,075 | 575,897
Depreciation
At 1 January 2025 | 323,417 | 38,128 | 40,215 | 57,488 | 459,248
Charge for the year | 31,587 | 380 | 23,748 | 5,782 | 61,497
Eliminated on disposal | (38,082) | (15,392) | - | (7,183) | (60,657)
At 31 December 2025 | 316,922 | 23,116 | 63,963 | 56,087 | 460,088
Carrying amount
At 31 December 2025 | 71,931 | 393 | 40,497 | 2,988 | 115,809
At 31 December 2024 | 84,130 | 773 | 64,245 | 8,770 | 157,918

Bakewell Veterinary Clinic Limited

Notes to the Unaudited Financial Statements for the Year Ended 31 December 2025 (continued)

5 | Debtors

| 2025 £ | 2024 £
Trade debtors | 338,459 | 356,325
Prepayments | 66,618 | 50,343
| 405,077 | 406,668

6 | Creditors

| 2025 £ | 2024 £
Due within one year |  |
Bank borrowings | 5,286 | 10,375
Trade creditors | 236,271 | 212,209
Taxation and social security | 235,527 | 265,798
Outstanding defined contribution pension costs | 4,832 | 4,246
Other creditors | 142,000 | 170,000
Accrued expenses | 134,726 | 7,191
| 758,642 | 669,819

| 2025 £ | 2024 £
Due after one year |  |
Bank borrowings | - | 5,286

7 | Financial commitments, guarantees and contingencies

Operating leases

The total amount of financial commitments not included in the balance sheet is £153,793 (2024 - £191,587).